Leadership & A-List
The Teva shareholder and digital printing pioneer thinks Teva should be investing in innovation, not cheap commodity drugs.
Hi, what are you looking for?
The Teva shareholder and digital printing pioneer thinks Teva should be investing in innovation, not cheap commodity drugs.
Mylan's filing on executive compensation reveals much higher pay than at Teva.
[FULL LETTER] After Mylan Responded aggressively to Teva's bid, Erez Vigodman says in an open letter to Robert Coury: Shareholders won't benefit from Mud...
Mylan, itself the subject of a hostile takeover bid from Teva, is raising its offer for Perrigo for the second time. Mylan N.V. has...
Julius Baer analyst Lilian Montero insists it's illogical for Mylan to remain independent.
Teva CEO Erez Vigodman bypasses Mylan's board and appeals directly to its shareholders.
Both Perrigo and Teva are down on the Tel Aviv Stock Exchange following the Independence Day break. After US-Israeli pharmaceuticals company Perrigo (PRGO) rejected...
Peres will receive $10, 000 a month; deal comes days after similar agreement with Bank Hapoalim canceled
Bloomberg reports that Teva is working with Barclays Bank on a takeover bid for Mylan.
The Perrigo stock weight in the TA-25 (derivatives) is 9.8%, second only to TEVA (10.5%).